| Company Name: |
Xi'an Confluore Biological Technology Co., Ltd.
|
| Tel: |
+86-156-80926068 +86-15680926068 |
| Email: |
1924344760@qq.com |
| Products Intro: |
Product Name:Propargyl-PEG13-bromide
CAS:2410937-34-5
Purity:95% HPLC Package:10MG;25MG;50MG;100MG;1G;5G Remarks:For customers outside China,please use the website:www.confluore.com
|
| Company Name: |
Beijing Jin Ming Biotechnology Co., Ltd.
|
| Tel: |
010-60605840 15801484223; |
| Email: |
psaitong@jm-bio.com |
| Products Intro: |
Product Name:Propargyl-PEG12-bromide
CAS:2410937-34-5
Purity:95% Package:100mg;250mg;1g
|
| Company Name: |
Affinity（Wuhan）Ltd.
|
| Tel: |
15841022315 |
| Email: |
sales@affinitytech.cn |
| Products Intro: |
Product Name:Propargyl-PEG12-Bromide
Purity:95% Package:1g;5g;10g;25g;100g
|
Propargyl-PEG12-bromide manufacturers
- Propargyl-PEG13-bromide
-
- $0.00 / 500mg
-
2024-03-26
- CAS:2410937-34-5
- Min. Order: 500mg
- Purity: >95.00%
- Supply Ability: 500mg
|
| | Propargyl-PEG12-bromide Basic information |
| Product Name: | Propargyl-PEG12-bromide | | Synonyms: | Propargyl-PEG12-bromide;inhibit,Propargyl PEG12 bromide,Inhibitor,PROTAC Linkers,Propargyl-PEG-12-bromide,PropargylPEG12bromide;3,6,9,12,15,18,21,24,27,30,33,36,39-Tridecaoxadotetracont-41-yne, 1-bromo- | | CAS: | 2410937-34-5 | | MF: | C29H55BrO13 | | MW: | 691.64 | | EINECS: | | | Product Categories: | | | Mol File: | 2410937-34-5.mol |  |
| | Propargyl-PEG12-bromide Chemical Properties |
| Boiling point | 648.9±50.0 °C(Predicted) | | density | 1.178±0.06 g/cm3(Predicted) |
| | Propargyl-PEG12-bromide Usage And Synthesis |
| Biological Activity | Propargyl-PEG12-bromide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | | References | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
| | Propargyl-PEG12-bromide Preparation Products And Raw materials |
|